SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?


To: Pogeu Mahone who wrote (432322)6/17/2011 2:49:50 PM
From: Joe Btfsplk  Read Replies (1) | Respond to of 794253
 
My friend`s J&J hip implant

Your friend's suffering represents a real conundrum without a crisp and perfect answer.

There is a learning curve in the development of complex products. Combine that with an imperfect knowledge of exactly how to replace failed body components and bad possibilities emerge exponentially.

The costs involved in perfecting implants will mostly be borne by future potential recipients. They'll either pay more or forgo opportunities.

Were I on a jury I'd be sympathetic to compensatory damages, but extremely wary of claims that DuPuy was intentionally negligent.

Again, a conundrum that should be more subject to economic analysis than emotional reaction.



To: Pogeu Mahone who wrote (432322)6/21/2011 8:40:49 AM
From: Alan Smithee  Read Replies (1) | Respond to of 794253
 
DePuy Orthopedics, a subsidiary of Johnson & Johnson, either knew or should have known about the significant problems associated with its now recalled hip implant devices.

Standard issue lawyer language. I have little doubt the entire quote was written by one of the class action lawyers involved in these cases.